The Recall Desk
Agency classClass IIOur severity:HighFDA (Devices)·Z-0708-2022·Announced 2022-03-09

OPAQUE Lacrimal Plugs recalled due to sterile pouch seal defect

Lacrimedics is recalling approximately 5,767 units of OPAQUE Lacrimal Plugs due to potential defects in the sterile pouch seal that could compromise product sterility. The affected devices were distributed nationwide and internationally.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Per the rubric, Class II recalls without reported hospitalizations score at most 3. This recall qualifies for score 3 (High) as a risk-of-harm product—a sterile medical device with compromised sterilization integrity—where no injuries have been reported.

Plain-English summary

OPAQUE Herrick Lacrimal Plugs are sterile medical devices manufactured by Lacrimedics Inc for treating dry eye disease. The devices are available in three sizes: HP3 (0.3 mm), HP5 (0.5 mm), and HP7 (0.7 mm). Approximately 5,767 units are being recalled.

The sterile pouch seal of these devices may contain channels that could affect seal integrity and potentially compromise product sterility. Lacrimedics Inc initiated this recall to address this defect.

The affected products were distributed nationwide and internationally. Specific lot numbers have been identified by Lacrimedics Inc and documented by the FDA.

The recalled product

Product
OPAQUE Herrick Lacrimal Plugs, HP3, 0.3 mm, HP5, 0.5mm, HP7, 0.7.mm, STERILE, EO, Rx only, CE Dry eye treatment
Manufacturer
Lacrimedics Inc
Affected units
5,767

Distribution

Distributed nationwide across the United States.

The notice also names 5 states specifically:

Part of a larger recall action

This product is one of 2 recalled by Lacrimedics Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Similar recalls